FDA stifled dangerous Vioxx results - expert
Washington - An expert with the United States Food and Drug Administration (FDA) has said on Thursday he was pressured by his agency to stifle study results showing the potential dangers of the anti-inflammatory drug Vioxx.
British regulators have extended their suspension of Chiron Corp.'s license to manufacture flu vaccine, jeopardizing the company's ability to sell millions of flu shots in the United States next flu season.